News & Insights
What to expect at this year's event
Access sessions from 2020 for free

Fireside Chat: Building a 21st century workforce
Amanda Poole, Senior Vice President, HR, Global Commercialisation at Bristol Myers Squibb in discussion with Hannah Kuchler, FT's US Pharma and Biotech Correspondent.

Fireside Chat: Innovate, accelerate, inoculate: Vaccines risk and opportunity
Roger Connor, President, Global Vaccines at GSK in discussion with Sarah Neville, FT's Global Pharmaceuticals Editor.

Panel: How technology is transforming R&D
What are the ways in which AI and big data are making/will make a meaningful impact in R&D, and where is pharma on its AI /data journey? How successful will pharma companies ultimately be in finding new ways to apply AI to big data sets to discover new drugs?
complete this short form for access to the playlist
Receive exclusive personalised events invitations, carefully-curated offers and promotions from Financial Times Live by Email
Receive exclusive personalised events invitations, carefully-curated offers and promotions from Financial Times Live by Phone
Please indicate that you accept the terms and conditions
For more information about how we use your data please refer to our privacy and cookie policies
<div fr-original-style="text-align: center; font-size:22px;" style="text-align: center; font-size: 22px; box-sizing: border-box;"> <a fr-original-style="" href="https://www.youtube.com/watch?v=gV2ImMzgRTM&list=PLLQ51Tq7D-Z5Q0Yu3wqCUrq5x0a2aUJ8l" style="background: 0px 0px; text-decoration: none; color: rgb(47, 134, 215); cursor: pointer; user-select: auto; box-sizing: border-box;" target="_blank">Click here</a> to access the sessions. </div>
Industry-related reading

FT Health: Future of Antibiotics
This report examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them even for viral infections, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain.

Research breakthroughs are accelerating cell therapy’s progress out of the lab and into the clinic. In this report we look at some of its most promising applications — including in the fight against Covid-19 — and examine the obstacles it still faces.

FT Health: Combating Coronavirus
As researchers race to develop a coronavirus vaccine, we look at efforts to ensure that the world’s poor are not left behind — and ask whether the pandemic will jolt policymakers into confronting the looming threat from antimicrobial resistance.
World-leading journalism and digital excellence
In a disrupted market, FT Live has partnered with world-leading event platform, Bizzabo, to bring you closer to the connections and content that matter. Based on a foundation of event innovation, trusted journalism, global audience reach, quality at scale and operational excellence, our 2021 Summits are taking content, sponsorship, attendee engagement opportunities to a new level.

© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice